Collagenna DermaResolve
Global General Technologies (www.glgt-corporate.com) subsidiary Collagenna Skin Care Products (http://collagenna-usa.com/1_5/) will soon introduce 2 new Peptide Based Products. Collagenna Skin Care Products, in collaboration with some major Peptide manufacturers, has developed 2 new formulations of Peptides with specific properties.
The first product, DermaResolve, is designed to help prevent the formation of expression wrinkles by attenuating muscular contractions, resulting in a “Botox effect” without the use of injections. The mechanism is different from Botox as it relaxes the facial muscles and helps prevent the formation of fine lines and wrinkles. There is much documented research to support these claims and we are also in the process of finalizing our own testing with a well know California dermatologist. The results of this test will be made known as they become available.
The second product is a Tanning Skin Care Product which contains a novel Peptide that boosts the tanning process as well as prolongs and maintains the sun tan. This exciting product means that people can achieve and maintain suntans with less exposure to the sun. The Peptide used in our formulation speeds up melanin production which results in faster and longer lasting tans.
Collagenna’s CEO Michael Arnkvarn states ” We know that UV radiation is very dangerous and causes skin cancer as well as being very damaging to the skin. Nobody should expose their skin to the sun without proper SPF protection and our product does not protect the skin. However, people still go out in the sun and our product can help them tan faster, maintain their tan longer and have less UV exposure. We feel that this product has huge market potential and will compliment our existing product line.” Both products are set to be released by the end of November 2009.
To be included in GLGT email database for press releases and industry updates, please subscribe at or opt in with your email address at this link http://www.minamargroup.com/updates/.
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment